Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.
这个发明的特定化合物是2-[2-(4-甲基-5-咪唑甲硫基)乙基氨基]-4-嘧啶酮。
Pharmacologically active compounds
申请人:Smith Kline & French Laboratories Limited
公开号:US04399142A1
公开(公告)日:1983-08-16
Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolymethylthio)ethylamino]-4-pyrimidone.
Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.
Pharmacologically active compounds as inhibitors of H-2 histamine
申请人:Smith Kline & French Laboratories Limited
公开号:US04181730A1
公开(公告)日:1980-01-01
Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.
Compositions and methods for inhibiting H.sub.2 histamine receptors
申请人:Smith Kline & French Laboratories Limited
公开号:US04005205A1
公开(公告)日:1977-01-25
Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.